Actualités Imi International Medical Innovations - IME | Actions American Stock Exchange

Imagin Medical Reports Progress in i/Blue™ Imaging System Functional Unit Development Phase

VANCOUVER, British Columbia and BOSTON, July 15, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB:...

Imagin Medical Announces Stock Option Grant

VANCOUVER, British Columbia and BOSTON, June 24, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB:...

Imagin Medical Reports Fiscal 2019 Second Quarter Results

VANCOUVER, British Columbia and BOSTON, June 11, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB:...

Imagin Medical to Report Second Fiscal Quarter 2019 Financial Results on June 11, 2019 – Conference Call to Follow

VANCOUVER, British Columbia and BOSTON, June 03, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB:...

Imagin Medical Welcomes World-Renowned Bladder Cancer Expert Dr. Ashish M. Kamat to Its Scientific Board of Advisors

VANCOUVER, British Columbia and BOSTON, April 17, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB:...

Imagin Medical Completes Assembly of i/Blue™ Imaging System Functional Unit

VANCOUVER, British Columbia and BOSTON, April 02, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB:...

IMI changes name to PreMD Inc.

New name reflects evolution of company from development-stage biotech to innovator in predictive medicine TORONTO, Sept. 27...

IMI completes bought-deal private placement financing

CDN$10 million/US$8.2 million financing positions IMI for future anticipated growth TORONTO, Aug. 30 /PRNewswire-FirstCall/ -- Predictive...

IMI announces bought-deal private placement financing

Enters into agreement for CDN$10 million/US$8.2 million TORONTO, Aug. 18 /PRNewswire-FirstCall/ -- Predictive medicine company IMI International...

IMI announces second quarter financial results and provides operational update

- Major ColorectAlert(TM) study with U.S. National Cancer Institute - 25,000-participant PREPARE study underway in life insurance testing market...

Allstate Life Insurance Company Participates in PREPARE Study to Evaluate New Medical Technology

Allstate teams up with IMI and McNeil Consumer Healthcare for non-invasive risk assessments TORONTO, Aug. 2 /PRNewswire-FirstCall/ -- Blood...

New data validates PREVU(x) LT Skin Sterol Test

New data validates PREVU(x) LT Skin Sterol Test Lab-processed format of PREVU(x) reliably measures skin sterol TORONTO, July 26...

Skin sterol linked to history of coronary events

Skin sterol linked to history of coronary events TORONTO, July 25 /PRNewswire-FirstCall/ -- Skin tissue cholesterol is strongly associated with...

IMI announces major clinical trial with ColorectAlert(TM)

IMI announces major clinical trial with ColorectAlert(TM) - Sponsored by U.S. National Cancer Institute's EDRN - Patented painless, low-cost...

IMI comments on market activity and Prevu(x) progress

IMI comments on market activity and Prevu(x) progress TORONTO, June 30 /PRNewswire-FirstCall/ -- In response to recent trading activity in the...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Imi International Medical Innovations (IME)

Votre Hub pour des idées et discussions en direct en temps réel

IME Actualités

Imagin Medical Reports Progress in i/Blue™ Imaging System Functional Unit Development Phase

Imagin Medical Announces Stock Option Grant

Imagin Medical Reports Fiscal 2019 Second Quarter Results

Imagin Medical to Report Second Fiscal Quarter 2019 Financial Results on June 11, 2019 – Conference Call to Follow

Imagin Medical Welcomes World-Renowned Bladder Cancer Expert Dr. Ashish M. Kamat to Its Scientific Board of Advisors

Imagin Medical Completes Assembly of i/Blue™ Imaging System Functional Unit

IMI changes name to PreMD Inc.

IMI completes bought-deal private placement financing

IMI announces bought-deal private placement financing

IMI announces second quarter financial results and provides operational update

Allstate Life Insurance Company Participates in PREPARE Study to Evaluate New Medical Technology

New data validates PREVU(x) LT Skin Sterol Test

Skin sterol linked to history of coronary events

IMI announces major clinical trial with ColorectAlert(TM)

IMI comments on market activity and Prevu(x) progress

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Imi International Medical Innovations (IME) Actualités

Imi International Medical Innovations (IME)

Votre Hub pour des idées et discussions en direct en temps réel

IME Actualités

Imagin Medical Reports Progress in i/Blue™ Imaging System Functional Unit Development Phase

Imagin Medical Announces Stock Option Grant

Imagin Medical Reports Fiscal 2019 Second Quarter Results

Imagin Medical to Report Second Fiscal Quarter 2019 Financial Results on June 11, 2019 – Conference Call to Follow

Imagin Medical Welcomes World-Renowned Bladder Cancer Expert Dr. Ashish M. Kamat to Its Scientific Board of Advisors

Imagin Medical Completes Assembly of i/Blue™ Imaging System Functional Unit

IMI changes name to PreMD Inc.

IMI completes bought-deal private placement financing

IMI announces bought-deal private placement financing

IMI announces second quarter financial results and provides operational update

Allstate Life Insurance Company Participates in PREPARE Study to Evaluate New Medical Technology

New data validates PREVU(x) LT Skin Sterol Test

Skin sterol linked to history of coronary events

IMI announces major clinical trial with ColorectAlert(TM)

IMI comments on market activity and Prevu(x) progress

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application